Recruiting NA Migraine in Children

New treatment option for Migraine in Children

Official title Association of Helicobacter Pylori Infection and Migraine

ClinicalTrials.gov ID: NCT06558578

What this study is testing

What it's testing
The study aims to assess the relation between migraine and H pylori infection in children and adolescent.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 6 to 16. Healthy volunteers may be eligible.

You may be able to join if

  • - children between 6 and 16 years old. Both sexes. children who suffering from migraine.

You likely can't join if

  • children below 6 years old\& children above 16 years old. Children suffering from epilepsy, Mental retardation, autism, attention deficient...

The study team makes the final eligibility decision.

Where it's taking place

  • Sohag, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 6 years to 16 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Sohag, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.